Department of Molecular and Cellular Pharmacology, University of Miami, Miami, FL 33101, USA.
Mol Biol Cell. 2011 Oct;22(19):3699-714. doi: 10.1091/mbc.E11-07-0628. Epub 2011 Aug 17.
The role of clathrin light chain (CLC) in clathrin-mediated endocytosis is not completely understood. Previous studies showed that the CLC N-terminus (CLC-NT) binds the Hip1/Hip1R/Sla2 family of membrane/actin-binding factors and that overexpression of the CLC-NT in yeast suppresses endocytic defects of clathrin heavy-chain mutants. To elucidate the mechanistic basis for this suppression, we performed synthetic genetic array analysis with a clathrin CLC-NT deletion mutation (clc1-Δ19-76). clc1-Δ19-76 suppressed the internalization defects of null mutations in three late endocytic factors: amphiphysins (rvs161 and rvs167) and verprolin (vrp1). In actin sedimentation assays, CLC binding to Sla2 inhibited Sla2 interaction with F-actin. Furthermore, clc1-Δ19-76 suppression of the rvs and vrp phenotypes required the Sla2 actin-binding talin-Hip1/R/Sla2 actin-tethering C-terminal homology domain, suggesting that clc1-Δ19-76 promotes internalization by prolonging actin engagement by Sla2. We propose that CLC directs endocytic progression by pruning the Sla2-actin attachments in the clathrin lattice, providing direction for membrane internalization.
网格蛋白轻链(CLC)在网格蛋白介导的胞吞作用中的作用尚不完全清楚。先前的研究表明,CLC N 端(CLC-NT)与 Hip1/Hip1R/Sla2 家族的膜/肌动蛋白结合因子结合,并且 CLC-NT 在酵母中的过表达可抑制网格蛋白重链突变体的胞吞缺陷。为了阐明这种抑制的机制基础,我们用网格蛋白 CLC-NT 缺失突变(clc1-Δ19-76)进行了合成遗传阵列分析。clc1-Δ19-76 抑制了三个晚期内吞因子的缺失突变的内化缺陷: amphiphysins(rvs161 和 rvs167)和 verprolin(vrp1)。在肌动蛋白沉淀试验中,CLC 与 Sla2 的结合抑制了 Sla2 与 F-肌动蛋白的相互作用。此外,clc1-Δ19-76 对 rvs 和 vrp 表型的抑制需要 Sla2 肌动蛋白结合 talin-Hip1/R/Sla2 肌动蛋白连接 C 末端同源结构域,表明 clc1-Δ19-76 通过延长 Sla2 的肌动蛋白结合来促进内化。我们提出,CLC 通过修剪网格蛋白晶格中的 Sla2-肌动蛋白附着物来指导内吞作用的进行,为膜内化提供了方向。